Atlas Trials

Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis

Clinical trial NCT01016262 · TERMINATED

Trial details

NCT number
NCT01016262
Sponsor
Forest Laboratories
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Proctitis, Ulcerative
Start date
2009-11-30
Primary completion
2011-07-31
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.